Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Clinical trial NCT07216391 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07216391
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2029-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.